XML 188 R49.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Collaboration Agreements - Vertex – 2016 Strategic Alliance in Cystic Fibrosis (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 31, 2019
USD ($)
extension_period
Jul. 31, 2016
USD ($)
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2018
USD ($)
Jun. 30, 2018
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jan. 01, 2019
USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]                            
Transaction price     $ 249,500,000               $ 249,500,000      
Deferred revenue     199,528,000       $ 240,924,000       199,528,000 $ 240,924,000    
Collaboration revenue     14,055,000 $ 17,046,000 $ 13,083,000 $ 16,025,000 35,421,000 $ 41,757,000 $ 28,851,000 $ 29,039,000 60,209,000 135,068,000 $ 205,825,000  
Revenue from contract with customer, excluding assessed tax                     60,209,000      
Collaboration revenue                            
Research and Development Arrangement, Contract to Perform for Others [Line Items]                            
Collaboration revenue                     42,803,000 76,519,000 146,953,000  
Revenue from contract with customer, excluding assessed tax                     42,803,000      
Vertex Agreement                            
Research and Development Arrangement, Contract to Perform for Others [Line Items]                            
Upfront cash payments   $ 20,000,000                        
Research period   3 years                        
Transaction price         4,100,000                 $ 24,400,000
Deferred revenue     $ 800,000       $ 3,300,000       800,000 3,300,000    
Research extension period 1 year                          
Proceeds from equity investment $ 20,000,000                          
Termination period 90 days                          
Termination period upon marketing approval 180 days                          
Research extension period elected 6 months                          
Revenue from contract with customer, excluding assessed tax $ 2,000,000                          
Research extension period 18 months                          
Number of extension periods | extension_period 2                          
Vertex Agreement | Collaboration revenue                            
Research and Development Arrangement, Contract to Perform for Others [Line Items]                            
Revenue from contract with customer, excluding assessed tax                     6,200,000 $ 10,400,000 $ 9,100,000  
Vertex Agreement | Development Milestones                            
Research and Development Arrangement, Contract to Perform for Others [Line Items]                            
Estimated arrangement consideration $ 55,000,000.0                          
Vertex Agreement | Regulatory Milestones                            
Research and Development Arrangement, Contract to Perform for Others [Line Items]                            
Estimated arrangement consideration 220,000,000.0                          
Vertex Agreement | Regulatory Milestones, Subsequent Products                            
Research and Development Arrangement, Contract to Perform for Others [Line Items]                            
Estimated arrangement consideration $ 3,000,000.0                          
Upfront Payment | Vertex Agreement                            
Research and Development Arrangement, Contract to Perform for Others [Line Items]                            
Transaction price         2,000,000                 20,000,000
Research And Development Funding | Vertex Agreement                            
Research and Development Arrangement, Contract to Perform for Others [Line Items]                            
Transaction price         $ 2,100,000                 $ 4,400,000
Change in estimation                     $ 100,000